Health & Bioscience
Research in health and biomedical sciences has a unique potential to improve peoples’ lives, and includes work ranging from basic science that aims to understand biology, to diagnosing individuals’ diseases, to epidemiological studies of whole populations. We recognize that our strengths in machine learning, large-scale computing, and human-computer interaction can help accelerate the progress of research in this space. By collaborating with world-class institutions and researchers and engaging in both early-stage research and late-stage work, we hope to help people live healthier, longer, and more productive lives.
Recent Publications
MoGen: Detailed Neuronal Morphology Generation via Point Cloud Flow Matching
Franz Rieger
International Conference on Learning Representations (ICLR) (2026)
Preview abstract
Biological neurons come in many shapes. High-fidelity generative modeling of their varied morphologies is challenging yet underexplored in neuroscience, and crucial for the subfield of connectomics. We introduce MoGen (Neuronal Morphology Generation), a flow matching model to generate high-resolution 3D point clouds of mouse cortex axon and dendrite fragments. This is enabled by an adaptation that injects local geometric context into a scalable latent transformer backbone, allowing for the generation of high-fidelity, realistic samples. To assess MoGen's generation quality, we propose a dedicated evaluation suite with interpretable geometric and topological features tailored to neuronal structures that we validate in a user study. MoGen's practical utility is showcased through controllable generation for visualization via smooth interpolation and a direct downstream application: we augment the training set of a shape plausibility classifier from a production connectomics neuron reconstruction pipeline with millions of generated samples, thereby improving classifier accuracy and reducing the number of remaining split and merge errors by 4.4%. We estimate this can reduce manual proofreading labor by over 157 person-years for reconstruction of a full mouse brain.
View details
Towards Conversational AI for Disease Management
Khaled Saab
David Stutz
Yong Cheng
Kavita Kulkarni
Sara Mahdavi
Joelle Barral
James Manyika
Ryutaro Tanno
Adam Rodman
Nature (2026)
Preview abstract
While large language models (LLMs) have shown promise in diagnostic dialogue, their capabilities for effective management reasoning - including disease progression, therapeutic response, and safe medication prescription - remain under-explored. We advance the previously demonstrated diagnostic capabilities of the Articulate Medical Intelligence Explorer (AMIE) through a new LLM-based agentic system optimised for clinical management and dialogue, incorporating reasoning over the evolution of disease and multiple patient visit encounters, response to therapy, and professional competence in medication prescription. To ground its reasoning in authoritative clinical knowledge, AMIE leverages Gemini's long-context capabilities, combining in-context retrieval with structured reasoning to align its output with relevant and up-to-date clinical practice guidelines and drug formularies. In a randomized, blinded virtual Objective Structured Clinical Examination (OSCE) study, AMIE was compared to 21 primary care physicians (PCPs) across 100 multi-visit case scenarios designed to reflect UK NICE Guidance and BMJ Best Practice guidelines. AMIE was non-inferior to PCPs in management reasoning as assessed by specialist physicians and scored better in both preciseness of treatments and investigations, and in its alignment with and grounding of management plans in clinical guidelines. To benchmark medication reasoning, we developed RxQA, a multiple-choice question benchmark derived from two national drug formularies (US, UK) and validated by board-certified pharmacists. While AMIE and PCPs both benefited from the ability to access external drug information, AMIE outperformed PCPs on higher difficulty questions. While further research would be needed before real-world translation, AMIE's strong performance across evaluations marks a significant step towards conversational AI as a tool in disease management.
View details
Preview abstract
As artificial intelligence (AI) is rapidly integrated into healthcare, ensuring that this innovation helps to combat health inequities requires engaging marginalized communities in health AI futuring. However, little research has examined Black populations’ perspectives on the use of AI in health contexts, despite the widespread health inequities they experience–inequities that are already perpetuated by AI. Addressing this research gap, through qualitative workshops with 18 Black adults, we characterize participants’ cautious optimism for health AI addressing structural well-being barriers (e.g., by providing second opinions that introduce fairness into an unjust healthcare system), and their concerns that AI will worsen health inequities (e.g., through health AI biases they deemed inevitable and the problematic reality of having to trust healthcare providers to use AI equitably). We advance health AI research by articulating previously-unreported health AI perspectives from a population experiencing significant health inequities, and presenting key considerations for future work.
View details
Performance analysis of updated Sleep Tracking algorithms across Google and Fitbit wearable devices
Arno Charton
Linda Lei
Siddhant Swaroop
Marius Guerard
Michael Dixon
Logan Niehaus
Shao-Po Ma
Logan Schneider
Ross Wilkinson
Ryan Gillard
Conor Heneghan
Pramod Rudrapatna
Mark Malhotra
Shwetak Patel
Google, Google, 1600 Amphitheatre Parkway
Mountain View, CA 94043 (2026) (to appear)
Preview abstract
Background: The general public has increasingly adopted consumer wearables for sleep tracking over the past 15 years, but reports on performance versus gold standards such as polysomnogram (PSG), high quality sleep diaries and at-home portable EEG systems still show potential for improved performance. Two aspects in particular are worthy of consideration: (a) improved recognition of sleep sessions (times when a person is in bed and has attempted to sleep), and (b) improved accuracy on recognizing sleep stages relative to an accepted standard such as PSG.
Aims: This study aimed to: 1) provide an update on the methodology and performance of a system for correctly recognizing valid sleep sessions, and 2) detail an updated description of how sleep stages are calculated using accelerometer and inter-beat intervals
Methods: Novel machine learning algorithms were developed to recognize sleep sessions and sleep stages using accelerometer sensors and inter-beat intervals derived from the watch or tracker photoplethysmogram. Algorithms were developed on over 3000 nights of human-scored free-living sleep sessions from a representative population of 122 subjects, and then tested on an independent validation set of 47 users. Within sleep sessions, an algorithm was developed to recognize periods when the user was attempting to sleep (Time-Attempting-To-Sleep = TATS). For sleep stage estimation, an algorithm was trained on human expert-scored polysomnograms, and then tested on 50 withheld subject nights for its ability to recognize Wake, Light (N1/N2), Deep (N3) and REM sleep relative to expert scored labels.
Results: For sleep session estimation, the algorithm had at least 95% overlap on TATS with human consensus scoring for 94% of nights from healthy sleepers. For sleep stage estimation, comparing with the current Fitbit algorithm, Cohen’s kappa for four-class determination of sleep stage increased from an average of 0.56 (std 0.13) to 0.63 (std 0.12), and average accuracy increased from 71% (std 0.10) to 77% (std 0.078)
Conclusion: A set of new algorithms has been developed and tested on Fitbit and Pixel Watches and is capable of providing robust and accurate measurement of sleep in free-living environments.
View details
Accurate human genome analysis with Element Avidity sequencing
Andrew Carroll
Daniel Cook
Lucas Brambrink
Bryan Lajoie
Kelly N. Wiseman
Sophie Billings
Semyon Kruglyak
Bryan R. Lajoie
Junhua Zhao
Shawn E. Levy
Kishwar Shafin
Maria Nattestad
BMC Bioinformatics (2025)
Preview abstract
We investigate the new sequencing technology Avidity from Element Biosciences. We show that Avidity whole genome sequencing matches mapping and variant calling accuracy with Illumina at high coverages (30x-50x) and is noticeably more accurate at lower coverages (20x-30x). We quantify base error rates of Element reads, finding lower error rates, especially in homopolymer and tandem repeat regions. We use Element’s ability to generate paired end sequencing with longer insert sizes than typical short–read sequencing. We show that longer insert sizes result in even higher accuracy, with long insert Element sequencing giving noticeably more accurate genome analyses at all coverages.
View details
A Scalable Framework for Evaluating Health Language Models
Neil Mallinar
Tony Faranesh
Brent Winslow
Nova Hammerquist
Ben Graef
Cathy Speed
Mark Malhotra
Shwetak Patel
Xavi Prieto
Daniel McDuff
Ahmed Metwally
(2025)
Preview abstract
Large language models (LLMs) have emerged as powerful tools for analyzing complex datasets. Recent studies demonstrate their potential to generate useful, personalized responses when provided with patient-specific health information that encompasses lifestyle, biomarkers, and context. As LLM-driven health applications are increasingly adopted, rigorous and efficient one-sided evaluation methodologies are crucial to ensure response quality across multiple dimensions, including accuracy, personalization and safety. Current evaluation practices for open-ended text responses heavily rely on human experts. This approach introduces human factors and is often cost-prohibitive, labor-intensive, and hinders scalability, especially in complex domains like healthcare where response assessment necessitates domain expertise and considers multifaceted patient data. In this work, we introduce Adaptive Precise Boolean rubrics: an evaluation framework that streamlines human and automated evaluation of open-ended questions by identifying gaps in model responses using a minimal set of targeted rubrics questions. Our approach is based on recent work in more general evaluation settings that contrasts a smaller set of complex evaluation targets with a larger set of more precise, granular targets answerable with simple boolean responses. We validate this approach in metabolic health, a domain encompassing diabetes, cardiovascular disease, and obesity. Our results demonstrate that Adaptive Precise Boolean rubrics yield higher inter-rater agreement among expert and non-expert human evaluators, and in automated assessments, compared to traditional Likert scales, while requiring approximately half the evaluation time of Likert-based methods. This enhanced efficiency, particularly in automated evaluation and non-expert contributions, paves the way for more extensive and cost-effective evaluation of LLMs in health.
View details
Some of our teams
×
![]()